Hogy Medical Co.,Ltd. (TYO:3593)
Japan · Delayed Price · Currency is JPY 6,660.00
0.00 (0.00%)
Inactive · Last trade price on May 14, 2026
Hogy Medical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue Revenue Growth | 37,841 | 39,138 | 39,100 | 38,981 | 36,778 | 36,504 |
Revenue Growth | -3.86% | 0.10% | 0.30% | 5.99% | 0.75% | -1.96% |
Gross Profit Gross Profit Growth | 12,222 | 12,621 | 13,063 | 15,740 | 15,417 | 15,327 |
Operating Income Operating Income Growth | 2,472 | 3,628 | 4,169 | 6,635 | 6,136 | 5,633 |
Net Income Net Income Growth | 222 | 1,520 | 2,804 | 4,316 | 4,370 | 4,959 |
Earnings Per Share EPS Growth | 10.30 | 67.95 | 115.54 | 177.93 | 152.99 | 164.03 |
EPS Growth | -91.91% | -41.19% | -35.06% | 16.30% | -6.73% | -10.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Investments Cash & Investments Growth | 18,284 | 22,005 | 19,419 | 18,862 | 14,364 | 20,549 |
Total Debt Total Debt Growth | 12,169 | 13,789 | 5,823 | 8,890 | 10,003 | 330 |
Net Cash (Debt) Net Cash Growth | 6,115 | 8,216 | 13,596 | 9,972 | 4,361 | 20,219 |
Net Cash Growth | -13.40% | -39.57% | 36.34% | 128.66% | -78.43% | -10.65% |
Net Cash Per Share Net Cash Per Share Growth | 283.58 | 367.28 | 560.24 | 411.10 | 152.68 | 668.80 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,653 | 11,555 | 7,117 | 9,176 | 8,501 | 6,854 |
Capital Expenditures CapEx Growth | -5,459 | -5,230 | -2,686 | -1,318 | -3,048 | -7,350 |
Free Cash Flow Free Cash Flow Growth | 194 | 6,325 | 4,431 | 7,858 | 5,453 | -496 |
Free Cash Flow Growth | -97.51% | 42.74% | -43.61% | 44.10% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Gross Margin | 32.30% | 32.25% | 33.41% | 40.38% | 41.92% | 41.99% |
Operating Margin | 6.53% | 9.27% | 10.66% | 17.02% | 16.68% | 15.43% |
Pretax Margin | 2.85% | 7.49% | 10.42% | 15.88% | 17.09% | 19.15% |
Profit Margin | 0.59% | 3.88% | 7.17% | 11.07% | 11.88% | 13.58% |
FCF Margin | 0.51% | 16.16% | 11.33% | 20.16% | 14.83% | -1.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 47.500 | 80.000 | 80.000 | 71.000 | 68.000 | 68.000 |
Dividend Per Share Growth | 9.38% | 0% | 12.68% | 4.41% | 0% | 3.03% |
Dividend Yield | 0.71% | 1.68% | 2.19% | 2.35% | 2.26% | 2.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | 646.77 | 68.08 | 32.46 | 17.84 | 21.35 | 20.59 |
Forward PE | - | 31.13 | 24.57 | 17.42 | 19.46 | 20.36 |
P/FCF Ratio | 740.12 | 16.36 | 20.54 | 9.80 | 17.11 | - |
PS Ratio | 3.79 | 2.64 | 2.33 | 1.98 | 2.54 | 2.80 |